Blood thinner may prevent stroke in heart muscle disease patients
NCT ID NCT07202897
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study tests whether the blood thinner rivaroxaban can prevent strokes in people with hypertrophic cardiomyopathy (HCM) who have early signs of heart strain but no irregular heartbeat. About 532 adults aged 40-80 with HCM and abnormal left atrial strain will be randomly assigned to take rivaroxaban or a placebo. The goal is to see if early use of this medication reduces the risk of stroke, heart attack, or death.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERTROPHIC CARDIOMYOPATHY (HCM) are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.